Results 151 to 160 of about 938,469 (359)
The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules [PDF]
, 2019 Beatriz G. de la Torre +1 more
openalex +1 more source
FEBS Open Bio, EarlyView.Chemotherapies such as doxorubicin can have toxic effects on healthy cardiovascular/heart tissue. Following up on a doxorubicin toxicity study in mice without tumors where nitrate water was cardioprotective (lessened toxicity), this study with tumor‐bearing mice undergoing doxorubicin treatment showed no negative effect of nitrate and nitrite on drug ...
Rama D. Yammani +7 more
wiley +1 more source
Potential conflicts in the fight against counterfeit drugs [PDF]
This analysis looks at the best way to deal with the proliferation of fake drugs, and considers the conflict that arises when government agencies aim to reduce the harmful effects of the fake medicine trade while the pharmaceutical firms seek profit ...
Berta Rivera, Luis Currais, Paolo Rungo
core
Exposing drug industry funding of UK patient organisations.
BMJ, 2019 Ozieranski P, Rickard E, Mulinari S.
europepmc +2 more sources
The Ethical Drug Industry: Practices And Performance.
, 1964 Leonard G. Schifrin
openalex +1 more source
FEBS Open Bio, EarlyView.This study addressed how a senior research thesis is perceived by undergraduate students. It assessed students' perception of research skills, epistemological beliefs, and career goals in Biochemistry (science) and BDC (science‐business) students. Completing a thesis improved confidence in research skills, resilience, scientific identity, closed gender‐
Celeste Suart +4 more
wiley +1 more source
HUMAN TRAFFICKING: THE BAHRAIN EXPERIENCE [PDF]
Drug smuggling may top the list of the world’s most profitable and headline-grabbing illegal activities, but second to that —in a close tie with the illegal arms trade — is human trafficking, the recruitment or coercion of people who are held captive as ...
Ali Al JABAL
core
Stagnation in the Drug Development Process: Are Patents the Problem? [PDF]
, 2007 The rate of new drug development has stagnated, in spite of large increases in both private and public sector spending on biomedical research. The flip side of slower progress is higher drug costs.
Dean Baker
core
Continuing evolution of the drug discovery process in the pharmaceutical industry [PDF]
, 2001 Emiliangelo Ratti, David G. Trist
openalex +1 more source